{"disease":{"id":"engraftment-syndrome","name":"engraftment syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05509933","title":"Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Henry Ford Health System","has_results":false},{"nct_id":"NCT00923845","title":"Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}